Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Rebecca E Glover"'
Publikováno v:
The Lancet Microbe, Vol 2, Iss 11, Pp e637-e644 (2021)
Summary: Antibiotic research and development is at an inflection point. Faced with ongoing problems with commercial innovation, we argue for a networked public approach to support and coordinate existing research and development initiatives by sustai
Externí odkaz:
https://doaj.org/article/aacf5652e8a54576992a5c2ec4b50189
Autor:
Gwenan M Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, Naomi M Fuller, Sam J Willcocks, Rumina Hasan, Esther van Kleef, Clare IR Chandler
Publikováno v:
eLife, Vol 10 (2021)
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analy
Externí odkaz:
https://doaj.org/article/a0c482ba9d674074885c1a67e80168d1
Autor:
Mark Petticrew, Rebecca E. Glover, Jimmy Volmink, Laurence Blanchard, Éadaoin Cott, Cécile Knai, Nason Maani, James Thomas, Alice Tompson, May C. I. van Schalkwyk, Vivian Welch
Publikováno v:
Systematic Reviews, Vol 12, Iss 1, Pp 1-14 (2023)
Abstract Background The field of the commercial determinants of health (CDOH) refers to the commercial products, pathways and practices that may affect health. The field is growing rapidly, as evidenced by the WHO programme on the economic and commer
Externí odkaz:
https://doaj.org/article/6657920d9164419da650a0ae4c31743e
Autor:
Michael McCaul, David Tovey, Taryn Young, Vivian Welch, Omar Dewidar, Mireille Goetghebeur, Tamara Kredo, Andrea C. Tricco, Rebecca E. Glover, Janice Tufte, Amir Qaseem, Reveiz Ludovic, Rebecca L. Morgan, Per Olav Vandvik, Ivan D. Florez
Publikováno v:
Journal of Clinical Epidemiology. 151:88-95
Autor:
Rebecca E Glover, Nichola R Naylor
Publikováno v:
JAC-Antimicrobial Resistance. 5
Objectives The development of national action plans (NAPs) for antimicrobial resistance (AMR) has been promoted and supported by the WHO, with recent support in the form of costing and budgeting tools to aid in finance-allocation decisions within gov
Publikováno v:
Critical Public Health. 33:197-206
Antimicrobial resistance (AMR) is often characterised as a ‘crisis’, requiring action by public, private, and third-sector stakeholders to achieve strategic change. Crisis narratives are powerful and may be co-opted to privilege solutions promote
Publikováno v:
The Lancet Microbe. 4:e2-e3
Publikováno v:
BMJ (Clinical research ed.). 376
Autor:
Elizabeth Eastmure, Rebecca E Glover, Nicholas Mays, Sharon J. Peacock, Mark Petticrew, Mustafa Al-Haboubi
OBJECTIVES: To demonstrate, using the example of a new systematic review of rapid diagnostic tests, how Sankey diagrams, alongside the PRISMA guidelines, can (i) facilitate reporting of the quality of the evidence base and (ii) help assess evidence s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e602a59d82420f4532cfa0edf07f46c
https://researchonline.lshtm.ac.uk/id/eprint/4664144/1/1-s2.0-S0895435621003905-main.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4664144/1/1-s2.0-S0895435621003905-main.pdf
Publikováno v:
BMJ (Clinical research ed.). 373